Senior insider sale
Exec. VP and CLO at PTC THERAPEUTICS, INC. — senior position signals high conviction
$1.78M
24.14K shares
BOULDING MARK ELLIOTT plans to sell 24.14K shares of PTC THERAPEUTICS, INC. valued at approximately $1.78M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Option Granted - 01/05/2023
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/6/2026 | Option Granted - 01/05/2023 Cash | 2.27K | — |
| Total | 2.27K | ||
Completed
Units to sell
3.02K
Market value
$209.8K
Units to sell
3.08K
Market value
$213.7K
Units to sell
2.81K
Market value
$194.9K
Units to sell
2.31K
Market value
$180.3K
Units to sell
4.03K
Market value
$308.8K
Units to sell
4.88K
Market value
$377.8K
Units to sell
1.74K
Market value
$133.8K
Planned — Approximate Date
Units to sell
2.27K
Market value
$157.3K
Units
24.14K
Value
$1.78M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/19/2026 | 3.02K | $209.8K | — | Completed |
2/18/2026 | 3.08K | $213.7K | — | Completed |
2/17/2026 | 2.81K | $194.9K | — | Completed |
1/9/2026 | 2.31K | $180.3K | — | Completed |
1/8/2026 | 4.03K | $308.8K | — | Completed |
1/7/2026 | 4.88K | $377.8K | — | Completed |
1/6/2026 | 1.74K | $133.8K | — | Completed |
| Planned — Approximate Date | ||||
4/6/2026 | 2.27K | $157.3K | NASDAQ | Planned |
| Total | 24.14K | $1.78M | ||